AbbVie Ordered to Pay 150 Million in AndroGel Lawsuit

Get the Full StoryA federal-court jury in Chicago ordered drugmaker AbbVie to pay 150 million in punitive damages to an Oregon man after finding the company liable for fraudulent misrepresentations about the safety of the testosterone-replacement therapy AndroGel, according to court records.

Share: